Drug class in one race
CDK4/6 drugs for HR+/HER2- Metastatic Breast Cancer
2 tracked CDK4/6 drugs in the HR+/HER2- Metastatic Breast Cancer race. The class explanation lives on the CDK4/6 page; the full indication pipeline across every mechanism is on the HR+/HER2- Metastatic Breast Cancer page.
1 Phase 31 Phase 1